PNPLA3 and metabolic dysfunction-associated steatohepatitis: While the PNPLA3 polymorphism rs738409 C/G variant has been reliably associated with an increased prevalence of NAFLD and the progression of the disease to NASH and hepatocellular carcinoma [70], little is currently known about specific genes involved in NAFLD risk.